Catherine Madigan - 01 Mar 2022 Form 3 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Signature
/s/ Michael A. Metzger, as Attorney-in-Fact
Issuer symbol
SNDX
Transactions as of
01 Mar 2022
Net transactions value
$0
Form type
3
Filing time
03 Mar 2022, 15:18:53 UTC
Next filing
03 Feb 2023

No securities are beneficially owned.